Using a special scan to detect and type basal cell carcinoma
Part of Cancer clinical trials.
This study is testing whether a special type of scan (called D-OCT) can accurately detect and classify a common type of skin cancer called basal cell carcinoma. The goal is to see if this scan can diagnose the cancer without needing a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to have a skin spot or bump that your doctor suspects could be a non-melanoma skin cancer or a pre-cancerous growth.
- You must have already had a special scan called a D-OCT scan and a skin biopsy as part of your regular care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This study tests a new imaging method called LC-OCT to look at basal cell carcinoma before Mohs surgery. It may help doctors see the tumor more clearly and plan the surgery better.
This trial is testing a new microscope technique that may help doctors see more clearly whether all cancer cells have been removed during standard skin cancer surgery. It could help make sure the surgery is successful the first time.
This trial is testing a special light-based technique (Raman spectroscopy) to see if it can help doctors better identify skin cancers. It is for people with either basal cell or squamous cell carcinoma who are scheduled to receive brachytherapy treatment.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
This study tests a high-resolution scan (called OCT) to better see skin tumors before they’re removed or biopsied. It may help doctors evaluate both non-pigmented and pigmented skin spots that look like possible skin cancer.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.